Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MeVO-TNK Ⅱ: Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke
NCT07302854Phase 3Recruiting
- Start
- Dec 2025
- Primary completion
- Dec 2028
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke. Started Dec 2025; status: recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07302854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07302854.